Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$16.93 - $31.33 $7,703 - $14,255
-455 Reduced 1.75%
25,617 $470,000
Q1 2024

Apr 30, 2024

BUY
$25.34 - $34.28 $68,113 - $92,144
2,688 Added 11.5%
26,072 $836,000
Q4 2023

Feb 05, 2024

SELL
$25.21 - $34.66 $100,008 - $137,496
-3,967 Reduced 14.5%
23,384 $638,000
Q3 2023

Nov 08, 2023

BUY
$26.91 - $35.49 $736,015 - $970,686
27,351 New
27,351 $813,000

Others Institutions Holding STVN

About Stevanato Group S.p.A.


  • Ticker STVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 264,700,000
  • Market Cap $5.44B
  • Description
  • Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machine...
More about STVN
Track This Portfolio

Track Van Eck Associates Corp Portfolio

Follow Van Eck Associates Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.